631222607	631222607	CD	B-NP	O
|	|	NN	I-NP	O
BMH	BMH	NN	I-NP	O
|	|	NN	I-NP	O
42971652	42971652	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2043451	2043451	CD	B-NP	O
|	|	CC	I-NP	O
9/11/2002	9/11/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/11/2002	9/11/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/8/2002	10/8/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MADU	MADU	NN	B-NP	O
,	,	,	O	O
HYMAN	HYMAN	NN	B-NP	O
370-24-48-0	370-24-48-0	CD	I-NP	O
Irvcheborageton	Irvcheborageton	NNP	I-NP	O
Die	Die	NNP	I-NP	O
Bay	Bay	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
9/11/02	9/11/02	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOELLER	TOELLER	NNP	B-NP	O
,	,	,	O	O
JACKIE	JACKIE	NNP	B-NP	O
EFRAIN	EFRAIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
.	.	.	O	O

CA	CA	NN	B-NP	O
+	+	SYM	O	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/17/02	6/17/02	CD	B-NP	O
by	by	IN	B-PP	O
AHYET	AHYET	NN	B-NP	B-protein
,	,	,	O	O
ELLIS	ELLIS	NNP	B-NP	O
GUILLERMO	GUILLERMO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3	3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
TOPROL	TOPROL	NNP	B-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

50	50	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
80	80	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
AND	AND	CC	O	O
IPRATROPIUM	IPRATROPIUM	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
INH	INH	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
Appt	Appt	NN	B-NP	O
with	with	IN	B-PP	O
local	local	JJ	B-NP	O
physician	physician	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Heugel	Heugel	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Vitanza	Vitanza	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
10/2/02	10/2/02	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
graig	graig	NN	B-NP	O
yancik	yancik	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Benadryl	Benadryl	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
diphenhydramine	diphenhydramine	NN	I-NP	O
hcl	hcl	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Atarax	Atarax	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hydroxyzine	hydroxyzine	NN	I-NP	O
hcl	hcl	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
rheumatic	rheumatic	JJ	I-NP	O
heart	heart	NN	I-NP	O
dz	dz	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
rheumatic	rheumatic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
MVR/AVR	MVR/AVR	NN	I-NP	O
s/p	s/p	NN	I-NP	O
replacement	replacement	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
Dellser	Dellser	NN	I-NP	O
Rangecan	Rangecan	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
tricuspid	tricuspid	JJ	I-NP	O
repair	repair	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
esophageal	esophageal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
61yoF	61yoF	NN	B-NP	O
urdu	urdu	NN	I-NP	O
speaking	speak	VBG	B-VP	O
Kansas	Kansas	NNP	B-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
historian	historian	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
MMP	MMP	NN	B-NP	B-protein
including	include	VBG	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
triple	triple	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
?	?	.	O	O

SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Hx	Hx	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
variable	variable	JJ	B-ADJP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
interview	interview	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
completed	complete	VBN	I-VP	O
outpatient	outpatient	NN	B-NP	O
rx	rx	NN	I-NP	O
for	for	IN	B-PP	O
bronchitis	bronchitis	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
approx	approx	NN	I-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
some	some	DT	B-NP	O
?	?	.	O	O

shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
medical	medical	JJ	B-NP	O
non	non	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ROS	ROS	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
n/v/d	n/v/d	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
/	/	SYM	I-NP	O
PND	PND	NN	I-NP	O
,	,	,	O	O
admits	admit	VBZ	B-VP	O
to	to	TO	I-VP	O
wt	wt	VB	I-VP	O
gain	gain	NN	B-NP	O
,	,	,	O	O
3lbs	3lb	NNS	B-NP	O
over	over	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
cough	cough	NN	B-NP	O
with	with	IN	B-PP	O
clear	clear	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
97.9	97.9	CD	B-NP	O
66	66	CD	I-NP	O
18136/61	18136/61	CD	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2l	2l	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
-	-	HYPH	B-NP	O
NCAT	NCAT	NN	I-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
PULM	PULM	NN	I-NP	O
-	-	HYPH	B-NP	O
Rhonchorus	Rhonchorus	NN	I-NP	O
through	through	IN	B-PP	O
both	both	CC	O	O
lung	lung	NN	B-NP	O
fields	field	NNS	I-NP	O
CARD	CARD	NN	I-NP	O
-	-	HYPH	B-VP	O
Irregular	Irregular	JJ	B-ADJP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
SEM	SEM	NN	I-NP	O
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
HS	HS	NN	I-NP	O
ABD	ABD	NN	I-NP	O
-	-	HYPH	O	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nt	nt	NN	I-NP	O
,	,	,	O	O
nd	nd	NN	B-NP	O
EXT-no	EXT-no	NN	I-NP	O
c/c	c/c	NN	I-NP	O
/	/	SYM	B-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
l	l	NN	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
A+P	A+P	NN	B-NP	O
-	-	HYPH	O	O
61yoF	61yoF	NN	B-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
mutiple	mutiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
difficult	difficult	JJ	B-NP	O
historian	historian	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
?	?	.	O	O

SOB	SOB	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
CARDS	CARDS	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Pt	Pt	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
diueresed	diuerese	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
soes	soe	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
,	,	,	O	O
either	either	CC	O	O
by	by	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
or	or	CC	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
Dig	Dig	NNP	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
additional	additional	JJ	I-NP	O
iv	iv	NN	I-NP	O
lasix	lasix	NN	I-NP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
neg	neg	NN	I-NP	O
1-2L	1-2L	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
ENDO	ENDO	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
Continue	Continue	JJ	I-NP	O
home	home	NN	I-NP	O
NPH	NPH	NN	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
PAIN	PAIN	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
Percocet	Percocet	NN	I-NP	O
prn	prn	NN	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
-	-	HYPH	B-NP	O
Nexium	Nexium	NN	I-NP	O
20	20	CD	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
FEN-Continue	FEN-Continue	JJ	I-NP	O
supplements	supplement	NNS	I-NP	O
6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HEME-Continue	HEME-Continue	JJ	I-NP	B-protein
coumadin	coumadin	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
ID-Afebrile	ID-Afebrile	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WBC	WBC	NNP	I-NP	B-cell_type
.	.	.	O	O

nothing	nothing	NN	B-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
Hospital	Hospital	NN	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
torsemide	torsemide	NN	I-NP	O
,	,	,	O	O
1-2	1-2	NN	B-NP	O
L/day	L/day	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CXR	CXR	NN	I-NP	B-protein
and	and	CC	I-NP	O
JVP	JVP	NN	I-NP	B-protein
markedly	markedly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
betablocker	betablocker	NN	I-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	I-VP	O
once	once	VB	I-VP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Repeat	Repeat	NNP	B-NP	O
CXR	CXR	NNP	I-NP	O
's	's	POS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
Call	Call	NN	B-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
for	for	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
from	from	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
-	-	:	O	O
Measure	Measure	NN	B-NP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
-	-	:	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
goes	go	VBZ	B-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
make	make	VB	I-VP	O
adjustments	adjustment	NNS	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
have	have	VBP	B-VP	O
VNA	VNA	NN	B-NP	B-protein
draw	draw	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
and	and	CC	O	O
check	check	NN	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
check	check	NN	I-NP	O
,	,	,	O	O
med	me	VBD	B-VP	O
compliance	compliance	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HARGEST	HARGEST	NNP	B-NP	O
,	,	,	O	O
JOHNNY	JOHNNY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HD52	HD52	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/11/02	9/11/02	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

